FOXP3型
生物
下调和上调
细胞生物学
转化生长因子
表型
T细胞
T细胞受体
免疫学
基因
免疫系统
生物化学
作者
Justin P. Edwards,Hodaka Fujii,Angela X. Zhou,John Creemers,Derya Unutmaz,Ethan M. Shevach
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2013-05-04
卷期号:190 (11): 5506-5515
被引量:90
标识
DOI:10.4049/jimmunol.1300199
摘要
GARP/LRRC32 was defined as a marker of activated human regulatory T cells (Tregs) that is responsible for surface localization of latent TGF-β1. We find that GARP and latent TGF-β1 are also found on mouse Tregs activated via TCR stimulation; however, in contrast to human Tregs, GARP is also expressed at a low level on resting Tregs. The expression of GARP can be upregulated on mouse Tregs by IL-2 or IL-4 exposure in the absence of TCR signaling. GARP is expressed at a low level on Tregs within the thymus, and Treg precursors from the thymus concomitantly express GARP and Foxp3 upon exposure to IL-2. The expression of GARP is independent of TGF-β1 and TGF-β1 loading into GARP and is independent of furin-mediated processing of pro-TGF-β1 to latent TGF-β1. Specific deletion of GARP in CD4(+) T cells results in lack of expression of latent TGF-β1 on activated Tregs. GARP-deficient Tregs develop normally, are present in normal numbers in peripheral tissues, and are fully competent suppressors of the activation of conventional T cells in vitro. Activated Tregs expressing GARP/latent TGF-β1 complexes are potent inducers of Th17 differentiation in the presence of exogenous IL-6 and inducers of Treg in the presence of IL-2. Induction of both Th17-producing cells and Tregs is caused preferentially by Tregs expressing the latent TGF-β1/GARP complex on their cell surface rather than by secreted latent TGF-β1.
科研通智能强力驱动
Strongly Powered by AbleSci AI